Seller record · Telehealth service

FitRx

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The home page and the answers refer only to partner pharmacies and United States based pharmacies, and the terms and privacy links in the footer lead to pages that are not found. 2 more criteria also fail; see the table below.

At a glance

FitRxTelehealth service

5/8criteria passed

Price: Compounded semaglutide from $151 a month on a three-month supply, plus a membership of $39 for the first month, then $135 a month
Sells: compounded semaglutide, compounded tirzepatide, Ozempic, and 7 more
FDA letters: 1 on file

Visit FitRx See all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A Beaumont, Texas telehealth service whose monthly membership covers weight loss care with compounded semaglutide or tirzepatide or insurance help for brand GLP-1 medications, alongside primary care, mental health, birth control, hair loss and skin care treatment.

Operating entity FitRx, Inc.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	FitRx's weight loss FAQ; FitRx's website
S2	Prescription gating	PASS	FitRx's weight loss page; FitRx's weight loss FAQ
S3	Pharmacy identification	FAIL	FitRx's website; FitRx's weight loss FAQ; FitRx's FAQ
S4	Compounding disclosure	FAIL	FitRx's weight loss page; FitRx's website; FitRx's weight loss FAQ
S5	Analytical documentation	FAIL	FitRx's website; FitRx's weight loss page; FitRx's weight loss FAQ
S6	Business address	PASS	FitRx's contact page; FitRx's website
S7	Price disclosure	PASS	FitRx's FAQ; FitRx's weight loss FAQ; FitRx's weight loss page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSThe weight-loss answers say providers are United States licensed, board-certified physicians and nurse practitioners, and that a licensed FitRx provider reviews each intake and prescribes only when clinically appropriate. No individual prescriber is named.Source: FitRx's weight loss FAQ; FitRx's website.

S2PASSThe steps list answering eligibility questions first and a provider's review second, the weight-loss start page opens on a question about the patient's goals, and the answers say medication is charged only if it is prescribed, after the prescription goes to a partner pharmacy.Source: FitRx's weight loss page; FitRx's weight loss FAQ.

S3FAILNo filling pharmacy is named. The home page and the answers refer only to partner pharmacies and United States based pharmacies, and the terms and privacy links in the footer lead to pages that are not found.Source: FitRx's website; FitRx's weight loss FAQ; FitRx's FAQ.

S4FAILThe home page footer says compounded drug products are not FDA-approved, but the weight-loss page sells semaglutide as the active ingredient in Ozempic and Wegovy beside other compounded GLP-1 medications and says GLP-1 medications with semaglutide are FDA-approved for type 2 diabetes, with no disclaimer on that page.Source: FitRx's weight loss page; FitRx's website; FitRx's weight loss FAQ.

S5FAILNo certificate of analysis or lot document is published on the home page, the weight-loss page or the answers.Source: FitRx's website; FitRx's weight loss page; FitRx's weight loss FAQ.

S6PASS2684 Calder Avenue, Beaumont, TX 77702, printed on the contact page with the support address. The home page footer names FitRx, Inc.Source: FitRx's contact page; FitRx's website.

S7PASSThe weight-loss membership costs $39 for the first month for a limited time, with the standard membership at $135 a month, and medication costs extra. Compounded semaglutide starts at $151 a month and compounded tirzepatide at $216 a month on a three-month supply. Bundles with the medication included cost $217 for the first month, then $297 a month for semaglutide, and $349 for the first month, then $449 a month for tirzepatide. Insured brand GLP-1 copays can be as low as $25 a month.Source: FitRx's FAQ; FitRx's weight loss FAQ; FitRx's weight loss page.

S8PASSFDA warning letter 717987, February 2026, names FitRX, LLC doing business as FitRx, reviews this website and writes to the support address it prints, at a New York address the site does not print. It says pictured labels named FitRx as the compounder of semaglutide and tirzepatide products and that claims naming them as the active ingredients in Wegovy, Ozempic, Zepbound and Mounjaro imply FDA approval. No FDA action has halted the business, and the seller still trades.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, Ozempic, Wegovy, Zepbound, Mounjaro, enclomiphene, birth control, hair loss and erectile dysfunction medications, mental health prescriptions.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide

Enforcement documents on file: 1 warning letter

FDA warning letter 717987, issued February 2026, to FitRX, LLC dba FitRxPictured labels identify FitRx as the compounder of semaglutide and tirzepatide products when it is not, and claims naming them as the active ingredients in Wegovy, Ozempic, Zepbound and Mounjaro imply the compounded products are FDA-approved when they are not.

A warning letter alleges violations and requests a response. It does not halt a business, and it does not remove a seller from this ledger. Every letter recorded here.

Visit FitRx

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.